Analysts think WVE stock price could increase by 244%
May 09, 2025, 11:25 AM
10.90%
What does WVE do
Wave Life Sciences is a clinical-stage biotechnology company focused on RNA medicines, utilizing its PRISM platform to develop treatments for disorders like Duchenne muscular dystrophy and Huntington’s disease. Founded in 2015, it employs 266 people and is advancing RNA-targeting modalities such as editing and interference.
14 analysts think WVE stock price will increase by 244.44%. The current median analyst target is $22.44 compared to a current stock price of $6.51. The lowest analysts target is $10.10 and the highest analyst target is $37.80.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
